Hutch News
Search and Filter
Results per Page:
Fred Hutch at CROI: COVID-19 vaccine efficacy trials, T-cell immunity following vaccination, immune responses to SARS-CoV-2, and late-breaking science on HPV, HIV and long-term antiretroviral therapy
Conference on Retroviruses and Opportunistic Infections to be held virtually March 6 – 10, 2021
Outlining the molecular networks that alter cell function and behavior
Dr. Taran Gujral’s NSF CAREER Award will allow him to study how cells shift to new functional states in normal development and disease
Tip Sheet: Diversity in vaccine clinical trials, behind-the-scenes look at COVID-19 biostats, new cell therapy approved, plus meet ‘Megasphaera hutchinsoni’
Summaries of recent Fred Hutch research findings and other news
Fred Hutch announces 2021 Harold M. Weintraub Graduate Student Award recipients
Thirteen graduate students selected for prestigious honor in biological sciences
Grad student Emma Wrenn receives Weintraub Award
13 recipients of prestigious award selected for research originality, innovation
New Scientific Publications
Each week, Fred Hutch librarians search PubMed and Web of Science to discover new papers published by Fred Hutch authors
Week of February 28, 2021
Women’s Health Initiative to continue
NIH awards a new $72M extension for the WHI Clinical Coordinating Center, housed at Fred Hutch
New bacterium named in honor of Fred Hutch
First organism named after research center linked to bacterial vaginosis, higher HIV risk
There’s no crystal ball for modeling the pandemic
Mathematical modelers explain challenges, limitations of their work to predict COVID-19 outcomes
Community engagement in HIV trials guides equity for COVID-19 vaccine studies
New study highlights longstanding barriers to diversity in prior decade of vaccine trials, despite federal guidelines
Learning to trust science with your life
Diseases like cancer and COVID-19 can be scary; leaning into the science helps you feel more empowered
Dedicated supporters at the Heart of the Hutch
Using creativity and passion to support Fred Hutch research in good times and bad
New study highlights lack of diversity and inclusion in vaccine clinical trials
Analysis shows certain racial/ethnic groups and older people aren’t being adequately represented and trial reporting guidelines aren’t being followed
Fundamental proteins that guide embryo development are co-opted by cancer
Researchers discover why some critical DNA-packaging proteins called histones evolve rapidly — and may give cancer a boost
Biostatisticians draft blueprints for COVID-19 vax trials
Hutch group applies skills honed during decades of HIV prevention trials to bring about safe and effective vaccines for a new pandemic
Hutch research helps launch new genomic medicine company
Ensoma receives $70 million in financing to develop genome modification technologies via a single injection
What's next for T-cell therapies: Q&A with Dr. Stanley Riddell
After approval of latest cellular therapy for non-Hodgkin lymphoma, the immunologist looks ahead
Fred Hutch statement regarding the FDA approval of CD19 immunotherapy, lisocabtagene maraleucel
The newly-approved CAR T-cell therapy was developed in part by Fred Hutch physician-scientists
Tip Sheet: COVID-19 vaccines, SARS-CoV-2 mutations, shedding pandemic pounds – and nematode nerve cells
Summaries of recent Fred Hutch research findings and other news
Could bacterial enzymes drive cancer formation by directly modifying human DNA?
W.M. Keck Foundation grant will help scientists pioneer new technologies to find out
New awards to spur innovation, commercialization in life sciences research
Funding from Washington Research Foundation continues longstanding collaboration with Fred Hutch